Type
Business expansion
Country
France
Region
Nord - Pas-De-Calais; Nord;
Location of affected unit(s)
Saint Amand les Eaux (Nord)
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

300 jobs
Number of planned job creations
Job creation
Announcement Date
29 September 2006
Employment effect (start)
1 December 2006
Foreseen end date
1 January 2009

Description

The British medical laboratory Glaxo Smith Kline (GSK) announced on 29 September 2006 that it is going to invest 500 million euro to increase its factory in Saint Amand les Eaux, in the north of France. The site, currently employing 125 people, will produce 'Cervarix' only, the future vaccine of GSK for the prevention of the cervix cancer. 300 new jobs are expected to be created between December 2006 and December 2009. The group also announced that it might create 300 additional jobs before 2011 if the new vaccine is successful. GSK employs 100,000 people in the world and 5,600 in France.


Sources

  • 2 October 2006: Les Echos
  • 2 October 2006: Le Figaro
  • 29 September 2006: AFP
  • 3 October 2006: Le Monde

Citation

Eurofound (2006), Glaxo Smith Kline, Business expansion in France, factsheet number 64168, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/64168.